Enhanced intestinal permeability of bufalin by a novel bufalin-peptide-dendrimer inclusion through caco-2 cell monolayer

Molecules

Volumn 22, Issue 12, 2017, Pages

  Chan, Chi On ^a   Jing, Jing ^b   Xiao, Wei ^c   Tan, Zhexu ^c   Lv, Qiuyue ^c   Yang, Jingyu ^d   Chen, Sibao ^a,c  

^a The Hong Kong Polytechnic University Shenzhen Research Institute   (Hong Kong)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c INSTITUTE OF MEDICINAL PLANT DEVELOPMENT   (China)

^d Shenzhen Pharmacists Association   (China)

Author keywords

Apparent permeability coefficient; Bufalin; Bufalin peptide dendrimer inclusion; Caco 2 cell monolayer; Intestinal permeability; Peptide dendrimer

Indexed keywords

BUFADIENOLIDE DERIVATIVE; BUFALIN; PEPTIDE;

CACO-2 CELL LINE; CELL SURVIVAL; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTESTINE; INTESTINE ABSORPTION; METABOLISM; PERMEABILITY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; TRANSPORT AT THE CELLULAR LEVEL;

BIOLOGICAL TRANSPORT; BUFANOLIDES; CACO-2 CELLS; CELL SURVIVAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; INTESTINAL ABSORPTION; INTESTINES; MOLECULAR STRUCTURE; PEPTIDES; PERMEABILITY; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 85040352702     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules22122088     Document Type: Article

References (29)

1. State Pharmacopoeia Committee of People's Republic of China. Pharmacopoeia of the People's Republic of China, 10th ed.; China Medical Science and Technology Press: Beijing, China, 2015; p. 383.
2. Xu, B.; Xia, H.; Zhao, X. Effect of concocting on bufadienolide in Bufonis Venenum. China J. Chin. Mater. Med. 1998, 23, 722-725.
3. Zhang, H.; Yin, Z.; Sheng, J.; Jiang, Z.; Wu, B.; Su, Y. A comparison study of pharmacokinetics between bufalin-loaded bovine serum albumin nanoparticles and bufalin in rats. J. Chin. Integr. Med. 2012, 10, 674-680. [CrossRef]
4. Su, Y.; Huang, X.; Zhang, D.; Zhang, Y.; Xie, J.; Linh, C. HPLC separation and determination of bufadienolide in cinobufacini injection. Chin. Tradit. Pat. Med. 2003, 25, 24-27.
5. Liu, Y.; Wang, P.; Sun, C.; Zhao, J.; Du, Y.; Shi, F.; Feng, N. Bioadhesion and enhanced bioavailability by wheat germ agglutinin-grafted lipid nanoparticles for oral delivery of poorly water-soluble drug bufalin. Int. J. Pharm. 2011, 419, 260-265. [CrossRef] [PubMed]
6. Senthil, K.M.; Valarmathi, S.; Bhima, P.; Prudhvi, D.S.; Raja, A.; Vallabhaneni, S.D. Dendrimers: A novel drug delivery system. J. Pharm. Sci. Technol. 2012, 4, 972-984.
7. Lombardo, D. Dendrimer-based host/guest systems for drug delivery. Mater. Sci. Res. J. 2014, 8, 403-431.
8. Prusty, A. Dendrimer: The recent drug delivery system. Int. Res. J. Pharm. 2012, 3, 10-12.
9. Rewatkar, P.V.; Parekh, H.S.; Parat, M.O. Molecular determinants of the cellular entry of asymmetric peptide dendrimers and role of caveolae. PLoS ONE 2016, 11, e0147491. [CrossRef] [PubMed]
10. Bugno, J.; Hsu, H.J.; Hong, S. Recent advances in targeted drug delivery approaches using dendritic polymers. Biomater. Sci. 2015, 3, 1025-1034. [CrossRef] [PubMed]
11. Kaneshiro, T.L.; Lu, Z.R. Targeted intracellular codelivery of chemotherapeutics and nucleic acid with a well-defined dendrimer-based nanoglobular carrier. Biomaterials 2009, 30, 5660-5666. [CrossRef] [PubMed]
12. Bosman, A.W.; Janssen, H.M.; Meijer, E.W. About Dendrimers: Structure, Physical Properties, and Applications. Chem. Rev. 1999, 99, 1665-1699. [CrossRef] [PubMed]
13. Vergara-Jaque, A.; Comer, J.; Monsalve, L.; Gonzalez-Nilo, F.D.; Sandoval, C. Computationally efcient methodology for atomic-level characterization of dendrimer-drug complexes: A comparison of amine-and acetyl-terminated PAMAM. J. Phys. Chem. B 2013, 117, 6801-6813. [CrossRef] [PubMed]
14. Song, Y.; Song, Y.; Hu, H.; Qiao, M.; Zhao, X.; Chen, W. Preparation and evaluation of doxorubicin loaded polyamide-amine dendrimer locked in liposome. J. Shenyang Pharm. Univ. 2013, 30, 663-668.
15. Mutalik, S.; Shetty, P.K.; Kumar, A.; Kalra, R.; Parekh, H.S. Enhancement in deposition and permeation of 5-fluorouracil through human epidermis assisted by peptide dendrimers. Drug Deliv. 2014, 21, 44-54. [CrossRef] [PubMed]
16. Shah, N.D.; Parekh, H.S.; Steptoe, R.J. Asymmetric peptide dendrimers are effective linkers for antibody-mediated delivery of diverse payloads to B cells in vitro and in vivo. Pharm. Res. 2014, 31, 3150-3160. [CrossRef] [PubMed]
17. Van Breemen, R.B.; Li, Y. Caco-2 cell permeability assays to measure drug absorption. Expert Opin. Drug Metab. Toxicol. 2005, 1, 175-185. [CrossRef] [PubMed]
18. Yee, S. In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man-fact or myth. Pharm. Res. 1997, 14, 763-766. [CrossRef] [PubMed]
19. Chong, S.; Dando, S.A.; Morrison, R.A. Evaluation of Biocoat intestinal epithelium differentiation environment (3-day culture Caco-2 cells) as an absorption screening model with improved productivity. Pharm. Res. 1997, 14, 1835-1837. [CrossRef] [PubMed]
20. Walle, U.K.; French, K.L.; Walgren, R.A.; Walle, T. Transport of genistein-7-glucoside by human intestinal Caco-2 cells: Potential role for MRP2. Res. Commun. Mol. Pathol. Pharmacol. 1999, 103, 45-56. [PubMed]
21. Wen, Z.; Li, G.; Lin, D.; Wang, J.; Qin, L.; Guo, G. Transport of PLGA nanoparticles across Caco-2/HT29-MTX co-cultured cells. Acta Pharm. Sin. 2013, 48, 1829-1835.
22. Lin, H.; Gebhardt, M.; Bian, S.; Kwon, K.A.; Shim, C.K.; Chung, S.J.; Kim, D.D. Enhancing effect of surfactants on fexofenadine. HCl transport across the human nasal epithelial cell monolayer. Int. J. Pharm. 2007, 330, 23-31. [CrossRef] [PubMed]
23. Alsenz, J.; Haenel, E. Development of a 7-day, 96-well Caco-2 permeability assay with high-throughput direct UV compound analysis. Pharm. Res. 2003, 20, 1961-1969. [CrossRef] [PubMed]
24. Kigen, G.; Edwards, G. Drug-transporter mediated interactions between anthelminthic and antiretroviral drugs across the Caco-2 cell monolayers. BMC Pharmacol. Toxicol. 2017, 18, 20. [CrossRef] [PubMed]
25. Mao, X.; Wu, L.; Zhao, H.; Liang, W.; Chen, W.; Han, S.; Qi, Q.; Cui, Y.; Li, S.; Yang, G.; et al. Transport of corilagin, gallic acid, and ellagic acid from fructus Phyllanthi tannin fraction in Caco-2 Cell Monolayers. Evid. Based Complement. Alternat. Med. 2016, 2016, 9205379. [CrossRef] [PubMed]
26. Zhou, W.; Di, L.; Wang, J.; Shan, J.; Liu, S.; Ju, W.; Cai, B. Intestinal absorption of forsythoside A in in situ single-pass intestinal perfusion and in vitro Caco-2 cell models. Acta Pharmacol. Sin. 2012, 33, 1069-1079. [CrossRef] [PubMed]
27. Yang, X.; Yang, X.; Wang, Y.; Ma, L.; Zhang, Y.; Yang, X.; Wang, K. Establishment of Caco-2 cell monolayer model and standard operation procedure for assessing intestinal absorption of chemical components of traditional Chinese medicine. J. Chin. Integr. Med. 2007, 5, 634-641. [CrossRef]
28. Artursson, P.; Karlsson, J. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem. Biophys. Res. Commun. 1991, 175, 880-885. [CrossRef]
29. Lennernäs, H.; Palm, K.; Fagerholm, U.; Artursson, P. Comparison between active and passive drug transport in human intestinal epithelial (Caco-2) cells in vitro and human jejunum in vivo. Int. J. Pharm. 1996, 127, 103-107. [CrossRef]